Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Girerd

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Revue Medicale Suisse|October 14, 2008
[Primary hyperaldosteronism in hypertension]Xavier Girerd
Presse Medicale (Paris, France : 1983)|February 24, 2009
[Hypertension in obese patients: Pathophysiology and management]Xavier Girerd, Boris Hansel
Current Medical Research and Opinion|July 22, 2004
Risk stratification for the prevention of cardiovascular complications of hypertensionXavier Girerd, Philippe Giral
Current Medical Research and Opinion|November 26, 2011
Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertensionDavid Rosenbaum, Xavier Girerd
Blood Pressure. Supplement|February 23, 2012
Efficacy and safety of early versus late titration of fixed-dose irbesartan/hydrochlorothiazide: ACTUAL studyXavier Girerd, David Rosenbaum, Joseph Aoun, et al.
Presse Medicale (Paris, France : 1983)|March 20, 2009
[Resistant hypertension: evaluation and treatment]Xavier Girerd, David Rosenbaum, Frédéric Villeneuve
Annales D'Endocrinologie|May 15, 2016
SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic stepsClaire Douillard, Pascal Houillier, Juerg Nussberger, et al.
Nephrologie & Therapeutique|October 18, 2020
[Impaired hypertension control in France: What the nephrologist needs to know]Sébastien Rubin, Romain Boulestreau, Thierry Couffinhal, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 24, 2007
A single-pill combination of amlodipine besylate and atorvastatin calcium (update)Roy Blank, F D Richard Hobbs, Jose Zamorano, et al.
Annales D'Endocrinologie|December 8, 2015
Questioning the pathogenic role of the pTyr791Phe mutation of the RET proto-oncogene: Insight from a case reportMaria Mavromati, Myriam Amsallem, Christel Jublanc, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Revue Medicale Suisse|October 14, 2008
[Primary hyperaldosteronism in hypertension]Xavier Girerd
Presse Medicale (Paris, France : 1983)|February 24, 2009
[Hypertension in obese patients: Pathophysiology and management]Xavier Girerd, Boris Hansel
Current Medical Research and Opinion|July 22, 2004
Risk stratification for the prevention of cardiovascular complications of hypertensionXavier Girerd, Philippe Giral
Current Medical Research and Opinion|November 26, 2011
Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertensionDavid Rosenbaum, Xavier Girerd
Blood Pressure. Supplement|February 23, 2012
Efficacy and safety of early versus late titration of fixed-dose irbesartan/hydrochlorothiazide: ACTUAL studyXavier Girerd, David Rosenbaum, Joseph Aoun, et al.
Presse Medicale (Paris, France : 1983)|March 20, 2009
[Resistant hypertension: evaluation and treatment]Xavier Girerd, David Rosenbaum, Frédéric Villeneuve
Annales D'Endocrinologie|May 15, 2016
SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic stepsClaire Douillard, Pascal Houillier, Juerg Nussberger, et al.
Nephrologie & Therapeutique|October 18, 2020
[Impaired hypertension control in France: What the nephrologist needs to know]Sébastien Rubin, Romain Boulestreau, Thierry Couffinhal, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 24, 2007
A single-pill combination of amlodipine besylate and atorvastatin calcium (update)Roy Blank, F D Richard Hobbs, Jose Zamorano, et al.
Annales D'Endocrinologie|December 8, 2015
Questioning the pathogenic role of the pTyr791Phe mutation of the RET proto-oncogene: Insight from a case reportMaria Mavromati, Myriam Amsallem, Christel Jublanc, et al.
Pageof 7